close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Nutriband Inc. - Common Stock (NQ:NTRB)

4.790 +0.110 (+2.35%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 20,749
Open 4.710
Bid (Size) 4.710 (100)
Ask (Size) 4.840 (100)
Prev. Close 4.680
Today's Range 4.590 - 4.840
52wk Range 3.722 - 11.78
Shares Outstanding 6,356,270
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
NetworkNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Announces Chairman Presentation at NobleCon21
Via Investor Brand Network
News headline image
REPEAT — Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch
From Nutriband Inc.
Via GlobeNewswire

Performance

YTD
+5.2%
+5.2%
1 Month
-31.9%
-31.9%
3 Month
-25.7%
-25.7%
6 Month
-19.9%
-19.9%
1 Year
+0.8%
+0.8%

More News

Read More
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Receives FDA Meeting Feedback Advancing AVERSA(TM) Fentanyl Toward 505(b)(2) NDA Submission
Via Investor Brand Network
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Via Benzinga
Nutriband Inc. (NASDAQ:NTRB) Targets the Opioid Safety Gap in a Multi-Billion-Dollar Market
Via AB Newswire
News headline image
Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch
From Nutriband Inc.
Via GlobeNewswire
InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Founder Gareth Sheridan Returns as CEO to Lead Final Development Phase of AVERSA Fentanyl
Via Investor Brand Network
Topics Intellectual Property
News headline image
Nutriband Co-Founder Gareth Sheridan Returns as CEO
From Nutriband Inc.
Via GlobeNewswire
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Featured in Channelchek Report Highlighting AVERSA Fentanyl Progress
Via Investor Brand Network
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Partners with Brand Institute to Develop Global Brand Identity for AVERSA FENTANYL
Via Investor Brand Network
News headline image
Nutriband Signs Agreement With Brand Institute to Develop the Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch
From Nutriband Inc.
Via GlobeNewswire
InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Files Provisional Patent to Strengthen Protection of AVERSA(TM) Abuse-Deterrent Technology
Via Investor Brand Network
Topics Intellectual Property
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) to Present at Noble Capital Markets Emerging Growth Virtual Equity Conference
Via Investor Brand Network
News headline image
Nutriband Files Provisional Patent Application for Enhanced Transdermal Abuse Deterrent Technology
From Nutriband Inc.
Via GlobeNewswire
News headline image
Nutriband To Present at the Noble Capital Markets’ Emerging Growth Virtual Equity Conference
From Nutriband Inc.
Via GlobeNewswire
InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) to Present at MicroCap Rodeo Conference
Via Investor Brand Network
News headline image
11 Company Presentations Today at The MicroCap Rodeo Conference
Via ACCESS Newswire
News headline image
Nutriband Inc. to Present at the MicroCap Rodeo Conference
From Nutriband Inc.
Via GlobeNewswire
MissionIRNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Eyes Clear Development Pathway for AVERSA(TM) Technology
Via Investor Brand Network
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Reports 51% Revenue Growth, Strong Cash Position to Advance AVERSA Fentanyl
Via Investor Brand Network
Nutriband Inc. (NASDAQ: NTRB): When Market Confidence Validates Scientific Innovation
Via Investor Brand Network
News headline image
Nutriband Inc. Quarterly Report Highlights Record Revenue for Q2, 2025 up 50.87% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl
From Nutriband Inc.
Via GlobeNewswire
InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Scales Manufacturing, Eyes Global Commercialization of AVERSA(TM)
Via Investor Brand Network
Topics Intellectual Property
Nutriband Inc. (NASDAQ: NTRB) CEO Showcases AVERSA(TM) Abuse Deterrent Transdermal Technology at Emerging Growth Conference
Via Investor Brand Network
Topics Initial Public Offering
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Secures $5.3 Million from Warrant Exercises to Advance AVERSA Fentanyl NDA
Via Investor Brand Network

Frequently Asked Questions

Is Nutriband Inc. - Common Stock publicly traded?
Yes, Nutriband Inc. - Common Stock is publicly traded.
What exchange does Nutriband Inc. - Common Stock trade on?
Nutriband Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Nutriband Inc. - Common Stock?
The ticker symbol for Nutriband Inc. - Common Stock is NTRB on the Nasdaq Stock Market
What is the current price of Nutriband Inc. - Common Stock?
The current price of Nutriband Inc. - Common Stock is 4.790
When was Nutriband Inc. - Common Stock last traded?
The last trade of Nutriband Inc. - Common Stock was at 11/25/25 04:00 PM ET
What is the market capitalization of Nutriband Inc. - Common Stock?
The market capitalization of Nutriband Inc. - Common Stock is 30.45M
How many shares of Nutriband Inc. - Common Stock are outstanding?
Nutriband Inc. - Common Stock has 30M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today